Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP5-874C20.8 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | CSGALNACT1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | PCSK7 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | MAP3K3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
mRNA | SLC25A14 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | CD9 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
mRNA | ZMAT3 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | TCHHL1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | SHROOM4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | FOXA2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |